{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:41:48Z","timestamp":1790937708696,"version":"4.1.0"},"reference-count":171,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.cgh.2006.06.010","type":"journal-article","created":{"date-parts":[[2006,8,18]],"date-time":"2006-08-18T11:13:37Z","timestamp":1155899617000},"page":"142-151","source":"Crossref","is-referenced-by-count":43,"title":["Dermatologic Disorders Associated With Chronic Hepatitis C: Effect of Interferon Therapy"],"prefix":"10.1016","volume":"5","author":[{"given":"David R.","family":"Berk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan Bayliss","family":"Mallory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmet B.","family":"Keeffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijaz","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2006.06.010_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00000441-200303000-00006","article-title":"Extrahepatic manifestations of hepatitis C infection","volume":"325","author":"Mayo","year":"2003","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.cgh.2006.06.010_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2036.2004.01919.x","article-title":"Hepatitis C virus\u2013related extrahepatic disease: aetiopathogenesis and management","volume":"20","author":"Medina","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.06.010_bib3","first-page":"2199","article-title":"Long-term course of mixed cryoglobulinemia in patients infected with hepatitis C virus","volume":"31","author":"Sene","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1067\/mjd.2001.109311","article-title":"Hepatitis C: a review and update","volume":"44","author":"Bonkovsky","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1468-3083.1998.tb00922.x","article-title":"Skin diseases associated with hepatitis C virus infection","volume":"10","author":"Hadziyannis","year":"1998","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.cgh.2006.06.010_bib6","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archderm.135.11.1401","article-title":"Hepatitis C virus\u2013related skin diseases","volume":"135","author":"Doutre","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0733-8635(02)00013-X","article-title":"Hepatitis C and the skin","volume":"20","author":"Jackson","year":"2002","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.cgh.2006.06.010_bib8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/00365520310000672a","article-title":"Porphyria cutanea tarda as a predictor of poor response to interferon alfa therapy in chronic hepatitis C","volume":"38","author":"Fernandez","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.06.010_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0733-8635(05)70235-7","article-title":"The interferons","volume":"19","author":"Edwards","year":"2001","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.cgh.2006.06.010_bib10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1053\/sarh.2002.37277","article-title":"Autoimmune disease complicating antiviral therapy for hepatitis C virus infection","volume":"32","author":"Wilson","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.cgh.2006.06.010_bib11","first-page":"2563","article-title":"Immunosuppression may lead to progression of hepatitis C virus\u2013associated liver disease in hemophiliacs coinfected with HIV","volume":"91","author":"Rockstroh","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.06.010_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.1840190203","article-title":"Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment","volume":"19","author":"Magrin","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.06.010_bib13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0016-5085(94)90077-9","article-title":"Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C","volume":"107","author":"Fong","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.06.010_bib14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.md.0000157577.69729.e6","article-title":"Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases","volume":"84","author":"Ramos-Casals","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cgh.2006.06.010_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0190-9622(88)80237-8","article-title":"Methotrexate in psoriasis: revised guidelines","volume":"19","author":"Roenigk","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00000478-198701000-00004","article-title":"Long-term effects of etretinate on the liver in psoriasis","volume":"11","author":"Camuto","year":"1987","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cgh.2006.06.010_bib17","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/rheumatology\/keg299","article-title":"Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection","volume":"42","author":"Ramos-Casals","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cgh.2006.06.010_bib18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/bega.1999.0076","article-title":"Complex management issues: management of HCV in the atypical patient","volume":"14","author":"Hadziyannis","year":"2000","journal-title":"Baillieres Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2006.06.010_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2000-9506","article-title":"Epidemiology of hepatitis C: geographic differences and temporal trends","volume":"20","author":"Wasley","year":"2000","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cgh.2006.06.010_bib20","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1365-2133.2004.06257.x","article-title":"Lichen planus and hepatitis C virus: a multicentre study of patients with oral lesions and a systematic review","volume":"151","author":"Lodi","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0168-8278(03)00399-4","article-title":"Prevalence of hepatitis C virus infection in porphyria cutanea tarda","volume":"39","author":"Fargion","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib22","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0168-8278(03)00346-5","article-title":"Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis","volume":"39","author":"Gisbert","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0168-8278(96)80113-9","article-title":"Side effects of high-dose interferon therapy for chronic hepatitis C","volume":"25","author":"Okanoue","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib24","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/archderm.135.8.1000","article-title":"High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus","volume":"135","author":"Sookoian","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib25","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00042737-199811000-00006","article-title":"A prospective evaluation of dermatological side effects during alpha-interferon therapy for chronic viral hepatitis","volume":"10","author":"Dalekos","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/000155501750376447","article-title":"Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus","volume":"81","author":"Manjon-Haces","year":"2001","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.cgh.2006.06.010_bib27","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1046\/j.1365-2133.2003.05481.x","article-title":"Cutaneous side effects of treatment of chronic hepatitis C by interferon alfa and ribavirin","volume":"149","author":"Kerl","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/00015550310007085","article-title":"Skin reaction in antiviral therapy for chronic hepatitis C: a role for polyethylene glycol interferon?","volume":"84","author":"Cottoni","year":"2004","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.cgh.2006.06.010_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000075046","article-title":"A prospective study of cutaneous adverse events induced by low-dose alpha-interferon treatment for malignant melanoma","volume":"208","author":"Guillot","year":"2004","journal-title":"Dermatology"},{"key":"10.1016\/j.cgh.2006.06.010_bib30","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1365-2133.2005.06931.x","article-title":"Clinical and immunological features of hepatitis C treatment\u2013associated dermatitis in 36 prospective cases","volume":"153","author":"Lubbe","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib31","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0168-8278(02)00067-3","article-title":"Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C","volume":"36","author":"Cacoub","year":"2002","journal-title":"J Hepatol"},{"issue":"Suppl 13","key":"10.1016\/j.cgh.2006.06.010_bib32","first-page":"S33","article-title":"Hepatitis C virus as a lymphotropic agent: evidence and pathogenetic implications","volume":"13","author":"Zignego","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib33","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/hep.1840190407","article-title":"Immunological disorders in C virus chronic active hepatitis: a prospective case-control study","volume":"19","author":"Pawlotsky","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.06.010_bib34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","article-title":"Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients","volume":"33","author":"Ferri","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.cgh.2006.06.010_bib35","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0046-8177(03)00193-X","article-title":"The dermatopathologic manifestations of hepatitis C infection: a clinical, histological, and molecular assessment of 35 cases","volume":"34","author":"Crowson","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cgh.2006.06.010_bib36","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1056\/NEJM199211193272104","article-title":"A role for hepatitis C virus infection in type II cryoglobulinemia","volume":"327","author":"Agnello","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2006.06.010_bib37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4065\/71.1.109","article-title":"Hepatitis C virus infection and cutaneous vasculitis in mixed cryoglobulinemia","volume":"71","author":"La Civita","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cgh.2006.06.010_bib38","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1046\/j.1523-1747.2002.00609.x","article-title":"Detection of hepatitis C virus RNA and core protein in keratinocytes from patients with cutaneous lichen planus and chronic hepatitis C","volume":"119","author":"Lazaro","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib39","first-page":"2371","article-title":"Hepatitis C virus RNA in the skin eruption from patients with prurigo and chronic hepatitis C","volume":"145","author":"Podanyi","year":"2004","journal-title":"Orv Hetil"},{"key":"10.1016\/j.cgh.2006.06.010_bib40","first-page":"63","article-title":"Generalized pustular psoriasis and hepatitis C virus infection","volume":"48","author":"Ujiie","year":"2004","journal-title":"Acta Virol"},{"key":"10.1016\/j.cgh.2006.06.010_bib41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00005792-200001000-00005","article-title":"Extrahepatic manifestations associated with hepatitis C virus infection: a prospective multicenter study of 321 patients","volume":"79","author":"Cacoub","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cgh.2006.06.010_bib42","first-page":"349","article-title":"Prevalence and clinical features of skin diseases in chronic HCV infection: a prospective study in 96 patients","volume":"44","author":"Paoletti","year":"2002","journal-title":"Panminerva Med"},{"key":"10.1016\/j.cgh.2006.06.010_bib43","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1001\/archderm.131.7.852","article-title":"Association of prurigo with hepatitis C virus infection","volume":"131","author":"Kanazawa","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib44","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-4362.1996.tb02997.x","article-title":"Necrolytic acral erythema: a cutaneous marker of viral hepatitis C","volume":"35","author":"el Darouti","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib45","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/archderm.135.8.1001","article-title":"Hepatitis C virus infection in cutaneous polyarteritis nodosa: a retrospective study of 16 cases","volume":"135","author":"Soufir","year":"1999","journal-title":"Arch Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.cgh.2006.06.010_bib46","doi-asserted-by":"crossref","first-page":"SII20","DOI":"10.3949\/ccjm.69.Suppl_2.SII20","article-title":"HCV and cryoglobulinemic vasculitis","volume":"69","author":"Ferri","year":"2002","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.cgh.2006.06.010_bib47","first-page":"S78","article-title":"HCV-related cryoglobulinemic vasculitis: an update on its etiopathogenesis and therapeutic strategies","volume":"21","author":"Ferri","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib48","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jcp.55.1.4","article-title":"Cryoglobulins","volume":"55","author":"Ferri","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.cgh.2006.06.010_bib49","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2893.1998.00097.x","article-title":"Systemic manifestations and liver disease in patients with chronic hepatitis C and type II or III mixed cryoglobulinaemia","volume":"5","author":"Donada","year":"1998","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.cgh.2006.06.010_bib50","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0168-8278(96)80200-5","article-title":"Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia","volume":"25","author":"Frangeul","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib51","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1046\/j.1365-2036.1999.00581.x","article-title":"Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus\u2013associated symptomatic mixed cryoglobulinaemia","volume":"13","author":"Calleja","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.06.010_bib52","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/archderm.131.10.1124","article-title":"Essential mixed cryoglobulinemia: a comparative study of dermatologic manifestations in patients infected or noninfected with hepatitis C virus","volume":"131","author":"Dupin","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib53","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00002281-200205000-00006","article-title":"Treatment of chronic hepatitis C infection with cryoglobulinemia","volume":"14","author":"Della Rossa","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib54","first-page":"2172","article-title":"Treatment of refractory, symptomatic, hepatitis C virus\u2013related mixed cryoglobulinemia with ribavirin and interferon-alpha","volume":"27","author":"Zuckerman","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib55","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/mus.10118","article-title":"Severe exacerbation of hepatitis C\u2013associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review","volume":"25","author":"Boonyapisit","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cgh.2006.06.010_bib56","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2604::AID-CNCR26>3.0.CO;2-V","article-title":"Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy","volume":"77","author":"Mazzaro","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.cgh.2006.06.010_bib57","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1182\/blood-2002-05-1537","article-title":"Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation","volume":"102","author":"Giannelli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cgh.2006.06.010_bib58","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.V81.5.1132.1132","article-title":"Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial","volume":"81","author":"Ferri","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.cgh.2006.06.010_bib59","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood.V90.10.3865","article-title":"Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection","volume":"90","author":"Casato","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.cgh.2006.06.010_bib60","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJM199403173301104","article-title":"Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus","volume":"330","author":"Misiani","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2006.06.010_bib61","first-page":"342","article-title":"Long-term effects of alpha-interferon therapy for type II mixed cryoglobulinemia","volume":"79","author":"Mazzaro","year":"1994","journal-title":"Haematologica"},{"key":"10.1016\/j.cgh.2006.06.010_bib62","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0168-8278(97)80281-4","article-title":"Interferon-alpha treatment of hepatitis C virus\u2013associated mixed cryoglobulinemia","volume":"27","author":"Polzien","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib63","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/ard.60.4.385","article-title":"Immunological and clinical follow-up of hepatitis C virus\u2013associated cryoglobulinaemic vasculitis","volume":"60","author":"Lamprecht","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cgh.2006.06.010_bib64","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10067-005-1093-x","article-title":"Vasculitic complications of interferon-alpha treatment for chronic hepatitis C virus infection: case report and review of the literature","volume":"24","author":"Beuthien","year":"2005","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib65","first-page":"1164","article-title":"Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus","volume":"32","author":"Levine","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib66","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.meg.0000108342.41221.0c","article-title":"Sustained exacerbation of cryoglobulinaemia-related vasculitis following treatment of hepatitis C with peginterferon alfa","volume":"16","author":"Batisse","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib67","first-page":"2466","article-title":"Long-term efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection","volume":"28","author":"Naarendorp","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib68","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood.V78.12.3142.3142","article-title":"Long-term results of therapy with interferon-alpha for type II essential mixed cryoglobulinemia","volume":"78","author":"Casato","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.cgh.2006.06.010_bib69","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jhep.2004.10.031","article-title":"Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study","volume":"42","author":"Mazzaro","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib70","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1182\/blood.V92.8.2983","article-title":"Interferon and ribavirin combination therapy in patients with chronic hepatitis C and mixed cryoglobulinemia","volume":"92","author":"Donada","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cgh.2006.06.010_bib71","first-page":"1775","article-title":"Interferon plus ribavirin in patients with hepatitis C virus\u2013positive mixed cryoglobulinemia resistant to interferon","volume":"30","author":"Mazzaro","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib72","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1002\/art.10699","article-title":"Interferon-alpha and ribavirin treatment in patients with hepatitis C virus\u2013related systemic vasculitis","volume":"46","author":"Cacoub","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cgh.2006.06.010_bib73","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.20958","article-title":"PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis","volume":"52","author":"Cacoub","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cgh.2006.06.010_bib74","first-page":"1115","article-title":"Ribavirin in hepatitis C\u2013related cryoglobulinemia","volume":"25","author":"Durand","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib75","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1440-0960.2000.00437.x","article-title":"Porphyria cutanea tarda","volume":"41","author":"Bleasel","year":"2000","journal-title":"Aust J Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib76","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2230.2001.00825.x","article-title":"The management of porphyria cutanea tarda","volume":"26","author":"Sarkany","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib77","first-page":"188","article-title":"Porphyria cutanea tarda, hepatitis C, alcoholism, and hemochromatosis: a case report and review of the literature","volume":"73","author":"Sams","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.cgh.2006.06.010_bib78","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2133.1974.tb06367.x","article-title":"Treatment of porphyria cutanea tarda with chloroquine","volume":"90","author":"Kordac","year":"1974","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib79","doi-asserted-by":"crossref","first-page":"308","DOI":"10.7326\/0003-4819-121-4-199408150-00018","article-title":"Porphyria cutanea tarda remission","volume":"121","author":"Siegel","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2006.06.010_bib80","first-page":"345","article-title":"Chronic hepatitis C associated with porphyria cutanea tarda","volume":"91","author":"Dohmen","year":"1994","journal-title":"Nippon Shokakibyo Gakkai Zasshi"},{"key":"10.1016\/j.cgh.2006.06.010_bib81","first-page":"1148","article-title":"Porphyria cutanea tarda and chronic hepatitis C: course after interferon therapy","volume":"18","author":"Grasset","year":"1994","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.cgh.2006.06.010_bib82","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0168-8278(95)80438-2","article-title":"Normalization of urinary porphyrin level and disappearance of skin lesions after successful interferon therapy in a case of chronic hepatitis C complicated with porphyria cutanea tarda","volume":"22","author":"Takikawa","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib83","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0248-8663(97)80846-6","article-title":"Familial porphyria cutanea tarda disclosed by chronic hepatitis C: apropos of a case","volume":"17","author":"About","year":"1996","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.cgh.2006.06.010_bib84","first-page":"525","article-title":"Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C","volume":"44","author":"Okano","year":"1997","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.cgh.2006.06.010_bib85","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1023\/A:1018854906444","article-title":"Dramatic resolution of skin lesions associated with porphyria cutanea tarda after interferon-alpha therapy in a case of chronic hepatitis C","volume":"43","author":"Sheikh","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2006.06.010_bib86","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/PL00009978","article-title":"Ineffective interferon treatment of chronic hepatitis C\u2013associated porphyria cutanea tarda, but with a transient decrease in HCV RNA levels","volume":"35","author":"Furuta","year":"2000","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.06.010_bib87","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000045980","article-title":"Development of porphyria cutanea tarda in a hemodialysis patient after reactivation of hepatitis C virus infection","volume":"88","author":"Albalate","year":"2001","journal-title":"Nephron"},{"key":"10.1016\/j.cgh.2006.06.010_bib88","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1053\/jhep.2002.35072","article-title":"Porphyria cutanea tarda during interferon\/ribavirin therapy for chronic hepatitis C","volume":"36","author":"Jessner","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.06.010_bib89","first-page":"302","article-title":"Porphyria cutanea tarda, dermatomyositis and non-Hodgkin lymphoma in virus C infection","volume":"13","author":"Bauza","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib90","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jhep.2004.10.029","article-title":"Occurrence of porphyria cutanea tarda during peginterferon\/ribavirin therapy for chronic viral hepatitis C","volume":"42","author":"Thevenot","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib91","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/j.1440-1746.2005.03249.x","article-title":"Pegylated interferon\u2013induced eyelid and eyebrow trichomegaly during chronic hepatitis C","volume":"20","author":"Howaizi","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib92","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1200\/JCO.1995.13.9.2401","article-title":"Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia","volume":"13","author":"Sacchi","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cgh.2006.06.010_bib93","first-page":"251","article-title":"Porphyria cutanea tarda in a patient with hairy cell leukemia","volume":"51","author":"Hacker","year":"1993","journal-title":"Cutis"},{"key":"10.1016\/j.cgh.2006.06.010_bib94","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0190-9622(98)70269-5","article-title":"Early-stage HIV infection and hepatitis C virus infection are associated with elevated serum porphyrin levels","volume":"39","author":"Lim","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib95","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/archderm.132.8.906","article-title":"Abnormal serum porphyrin levels in patients with the acquired immunodeficiency syndrome with or without hepatitis C virus infection","volume":"132","author":"Nomura","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib96","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/archderm.132.12.1443","article-title":"Porphyrin abnormalities in acquired immunodeficiency syndrome","volume":"132","author":"O\u2019Connor","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib97","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1001\/archderm.132.12.1448","article-title":"Abnormal urinary coproporphyrin levels in patients infected by hepatitis C virus with or without human immunodeficiency virus: a study of 177 patients","volume":"132","author":"Cribier","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib98","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0781.1996.tb00241.x","article-title":"Porphyrin metabolism in hepatitis C infection","volume":"12","author":"O\u2019Reilly","year":"1996","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.cgh.2006.06.010_bib99","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1365-2230.1996.tb00095.x","article-title":"The association of hepatitis C viral infection with porphyria cutanea tarda in the Lothian region of Scotland","volume":"21","author":"Hussain","year":"1996","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib100","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1046\/j.1440-1746.2000.02065.x","article-title":"Effect of hepatobiliary disease, chronic hepatitis C and hepatitis B virus infections and interferon-alpha on porphyrin profiles in plasma, urine and faeces","volume":"15","author":"Gibson","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib101","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1023\/A:1026681218915","article-title":"Highly active antiretroviral therapy leading to resolution of porphyria cutanea tarda in a patient with AIDS and hepatitis C","volume":"44","author":"Rich","year":"1999","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2006.06.010_bib102","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1540-9740.2002.01649.x","article-title":"Lichen planus","volume":"1","author":"Goldblum","year":"2002","journal-title":"Skinmed"},{"key":"10.1016\/j.cgh.2006.06.010_bib103","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1067\/mjd.2002.120452","article-title":"The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients","volume":"46","author":"Eisen","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib104","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0733-8635(02)00067-0","article-title":"The clinical manifestations and treatment of oral lichen planus","volume":"21","author":"Eisen","year":"2003","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.cgh.2006.06.010_bib105","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0168-8278(05)80642-7","article-title":"Exacerbation of lichen planus but not of acute intermittent hepatic porphyria during interferon therapy in a patient with chronic hepatitis C","volume":"21","author":"Heintges","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib106","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000247552","article-title":"Lichen planus and virus C hepatitis: disappearance of the lichen under interferon alfa therapy","volume":"184","author":"Doutre","year":"1992","journal-title":"Dermatology"},{"key":"10.1016\/j.cgh.2006.06.010_bib107","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2340\/0001555572380","article-title":"The relation between lichen planus and hepatitis C: a case report","volume":"72","author":"Agner","year":"1992","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.cgh.2006.06.010_bib108","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-4362.1993.tb01482.x","article-title":"UVA and interferon-alfa therapy in a patient with lichen planus and chronic hepatitis C","volume":"32","author":"Strumia","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib109","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0016-5085(93)91029-H","article-title":"Exacerbation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis C","volume":"104","author":"Protzer","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.06.010_bib110","first-page":"764","article-title":"Eruptive mucocutaneous lichen planus during treatment of chronic hepatitis C with interferon alpha","volume":"17","author":"Sassigneux","year":"1993","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.cgh.2006.06.010_bib111","first-page":"610","article-title":"Lichen planus during chronic hepatitis C treated with interferon alpha","volume":"16","author":"d\u2019Agay-Abensour","year":"1992","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.cgh.2006.06.010_bib112","first-page":"1051","article-title":"Mucocutaneous lichen planus induced by a second treatment with high-dose interferon-alpha in a patient with chronic viral hepatitis C","volume":"18","author":"Perreard","year":"1994","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.cgh.2006.06.010_bib113","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-4362.1994.tb04993.x","article-title":"Sudden onset of oral ulcerative lichen in a patient with chronic hepatitis C on treatment with alfa-interferon","volume":"33","author":"Papini","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib114","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/hep.1840210649","article-title":"Lichen planus, chronic hepatitis C and interferon","volume":"21","author":"Frider","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.06.010_bib115","first-page":"550","article-title":"Lichen planus and hepatitis C virus infection: study of 6 cases","volume":"195","author":"Revenga Arranz","year":"1995","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.cgh.2006.06.010_bib116","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/00004836-199506000-00028","article-title":"Lichen planus during lymphoblastoid interferon treatment for chronic active hepatitis C","volume":"20","author":"Fornaciari","year":"1995","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2006.06.010_bib117","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1346-8138.1995.tb03424.x","article-title":"Appearance of oral erosive lichen planus during interferon alfa-2a therapy for chronic active hepatitis C","volume":"22","author":"Nunez","year":"1995","journal-title":"J Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib118","first-page":"367","article-title":"Lichen planus induced by interferon-alpha 2a therapy for chronic active hepatitis C","volume":"7","author":"Barreca","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib119","first-page":"833","article-title":"Lichen planus and hepatitis C virus: apropos of 5 new cases","volume":"19","author":"Hyrailles","year":"1995","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.cgh.2006.06.010_bib120","first-page":"709","article-title":"Lichen planus and hepatitis C: heterogeneity in the course of 6 cases treated with interferon alpha","volume":"20","author":"Doutre","year":"1996","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.cgh.2006.06.010_bib121","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0168-8278(96)80184-X","article-title":"A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon","volume":"24","author":"Fattovich","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib122","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1046\/j.1365-2362.1996.610607.x","article-title":"Development and exacerbation of oral lichen planus during and after interferon therapy for hepatitis C","volume":"26","author":"Nagao","year":"1996","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cgh.2006.06.010_bib123","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0016-5085(99)70595-0","article-title":"Histological improvement of oral lichen planus in patients with chronic hepatitis C treated with interferon","volume":"117","author":"Nagao","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.06.010_bib124","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2340\/0001555577171172","article-title":"Successful interferon treatment for lichen planus associated with chronic active hepatitis due to hepatitis C virus infection","volume":"77","author":"Lapidoth","year":"1997","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.cgh.2006.06.010_bib125","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0190-9622(97)80296-4","article-title":"Oral erosive lichen planus with epidermolytic hyperkeratosis during interferon alfa-2b therapy for chronic hepatitis C virus infection","volume":"36","author":"Schlesinger","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib126","first-page":"239","article-title":"Oral lichen planus induced by interferon-alpha-N1 in a patient with hepatitis C","volume":"39","author":"Varela","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib127","first-page":"568","article-title":"Clinical evaluation in oral lichen planus with chronic hepatitis C: the role of interferon treatment","volume":"97","author":"Sugiyama","year":"2000","journal-title":"Nippon Shokakibyo Gakkai Zasshi"},{"key":"10.1016\/j.cgh.2006.06.010_bib128","first-page":"358","article-title":"Presence of lichen planus during a course of interferon alpha-2a therapy for a viral chronic C hepatitis","volume":"6","author":"Guijarro Guijarro","year":"2001","journal-title":"Med Oral"},{"key":"10.1016\/j.cgh.2006.06.010_bib129","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0190-9622(03)02089-9","article-title":"Lichen planus associated with hepatitis C virus: no viral transcripts are found in the lichen planus, and effective therapy for hepatitis C virus does not clear lichen planus","volume":"49","author":"Harden","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1468-3083.2003.00583.x","article-title":"Lichen planus and leukocytoclastic vasculitis induced by interferon alpha-2b in a subject with HCV-related chronic active hepatitis","volume":"17","author":"Pinto","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.cgh.2006.06.010_bib131","first-page":"237","article-title":"Exacerbation of oral erosive lichen planus by combination of interferon and ribavirin therapy for chronic hepatitis C","volume":"15","author":"Nagao","year":"2005","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.cgh.2006.06.010_bib132","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/0190-9622(95)90427-1","article-title":"Successful treatment of generalized lichen planus with recombinant interferon alfa-2b","volume":"33","author":"Hildebrand","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib133","first-page":"284","article-title":"Successful treatment of extensive lichen planus and ulcerous oral lesions with recombinant interferon-gamma","author":"Engelmann","year":"1992","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.cgh.2006.06.010_bib134","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1601-0825.1998.tb00271.x","article-title":"IFN-alpha cream in the treatment of oral lichen planus","volume":"4","author":"Pedersen","year":"1998","journal-title":"Oral Dis"},{"key":"10.1016\/j.cgh.2006.06.010_bib135","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1365-2133.1997.tb01138.x","article-title":"Oropharyngeal lichen planus associated with interferon-alpha treatment for mycosis fungoides: a rare side effect in the therapy of cutaneous lymphomas","volume":"137","author":"Kutting","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib136","first-page":"29","article-title":"Lichen plan induit par l\u2019interferon alpha 2b chez un malade avec un myeloma a IgG","volume":"8","author":"Rodrigues","year":"1989","journal-title":"Nouv Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib137","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/000155599750010418","article-title":"Lichen planus induced by interferon-alpha 2B therapy in a patient with cutaneous malignant melanoma","volume":"79","author":"Herrera Saval","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.cgh.2006.06.010_bib138","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1365-2133.2003.05422.x","article-title":"Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection","volume":"149","author":"Willems","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib139","first-page":"554","article-title":"Rosacea fulminans associated with pegylated interferon alpha-2B and ribavirin therapy","volume":"2","author":"Jensen","year":"2003","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib140","first-page":"570","article-title":"Multiple fixed drug eruption with interferon\/ribavirin combination therapy for hepatitis C virus infection","volume":"2","author":"Sidhu-Malik","year":"2003","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib141","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/archderm.135.11.1335","article-title":"Chronic urticaria is not significantly associated with hepatitis C or hepatitis G infection: a case-control study","volume":"135","author":"Cribier","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib142","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM199811193392102","article-title":"Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C","volume":"339","author":"Davis","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2006.06.010_bib143","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","article-title":"Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C","volume":"339","author":"McHutchison","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2006.06.010_bib144","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-4362.1996.tb02977.x","article-title":"Hepatitis C virus antibody (anti-HCV): prevalence in psoriasis","volume":"35","author":"Chouela","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib145","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1001\/archderm.132.11.1391","article-title":"Hepatitis C virus infection in patients with psoriasis","volume":"132","author":"Kanazawa","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib146","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2340\/0001555575482483","article-title":"Psoriasis and hepatitis C virus","volume":"75","author":"Yamamoto","year":"1995","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.cgh.2006.06.010_bib147","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000246673","article-title":"Chronic hepatitis C infection and psoriasis","volume":"190","author":"Burrows","year":"1995","journal-title":"Dermatology"},{"key":"10.1016\/j.cgh.2006.06.010_bib148","first-page":"370","article-title":"Hepatitis C virus infection: prevalence in psoriasis and psoriatic arthritis","volume":"26","author":"Taglione","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib149","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/art.21079","article-title":"Hepatitis C virus infection in psoriatic arthritis","volume":"53","author":"Palazzi","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cgh.2006.06.010_bib150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/03009749709065666","article-title":"Psoriatic arthritis with spinal involvement in a patient receiving alpha-interferon for chronic hepatitis C","volume":"26","author":"Lombardini","year":"1997","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib151","first-page":"423","article-title":"The exacerbation of psoriasis during treatment with alfa interferon","volume":"88","author":"Pellicano","year":"1997","journal-title":"Recenti Prog Med"},{"key":"10.1016\/j.cgh.2006.06.010_bib152","first-page":"512","article-title":"Interferon-alpha and development of psoriatic arthropathy","volume":"13","author":"Piqueras Alcol","year":"1996","journal-title":"An Med Int"},{"key":"10.1016\/j.cgh.2006.06.010_bib153","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s001050050388","article-title":"Interferon-alpha-induced psoriasis vulgaris","volume":"47","author":"Wolfer","year":"1996","journal-title":"Hautarzt"},{"key":"10.1016\/j.cgh.2006.06.010_bib154","first-page":"324","article-title":"The treatment of hepatitis B and C with interferon-alpha can induce or aggravate psoriasis","volume":"19","author":"Cervoni","year":"1995","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.cgh.2006.06.010_bib155","first-page":"1771","article-title":"Arthritis in a patient with psoriasis after interferon-alpha therapy for chronic hepatitis C","volume":"21","author":"Makino","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib156","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/pmj.76.896.365","article-title":"Extensive psoriasis induced by interferon alfa treatment for chronic hepatitis C","volume":"76","author":"Taylor","year":"2000","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.cgh.2006.06.010_bib157","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000018447","article-title":"Psoriasis associated with HCV and exacerbated by interferon alpha: complete clearance with acitretin during interferon alpha treatment for chronic active hepatitis","volume":"201","author":"Erkek","year":"2000","journal-title":"Dermatology"},{"key":"10.1016\/j.cgh.2006.06.010_bib158","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1046\/j.1365-2230.2000.00655-4.x","article-title":"Exacerbation of psoriasis by interferon-alpha therapy for hepatitis C","volume":"25","author":"Downs","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib159","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000085626","article-title":"Exacerbation of psoriasis due to peginterferon alpha-2b plus ribavirin treatment of chronic active hepatitis C","volume":"51","author":"Kartal","year":"2005","journal-title":"Chemotherapy"},{"key":"10.1016\/j.cgh.2006.06.010_bib160","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0248-8663(01)00398-8","article-title":"Sarcoidosis and comorbidity: retrospective study of 32 cases","volume":"22","author":"Bonnet","year":"2001","journal-title":"Rev Med Intern"},{"key":"10.1016\/j.cgh.2006.06.010_bib161","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/oxfordjournals.epirev.a036255","article-title":"Epidemiology of sarcoidosis","volume":"5","author":"Bresnitz","year":"1983","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.cgh.2006.06.010_bib162","first-page":"1006","article-title":"Systemic sarcoidosis associated with interferon-alpha treatment for chronic myelogenous leukemia","volume":"85","author":"Fiorani","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.cgh.2006.06.010_bib163","first-page":"304","article-title":"Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa","volume":"20","author":"Carson","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib164","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s005350070040","article-title":"Manifestation of cutaneous polyarteritis nodosa during interferon therapy for chronic hepatitis C associated with primary biliary cirrhosis","volume":"35","author":"Dohmen","year":"2000","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.06.010_bib165","first-page":"9","article-title":"Pruritis and the hepatitis C virus","volume":"125","author":"Dega","year":"1998","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.cgh.2006.06.010_bib166","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0168-8278(98)80216-X","article-title":"Hyde\u2019s prurigo nodularis and chronic HCV hepatitis","volume":"28","author":"Neri","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib167","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/cyto.2000.0807","article-title":"Successful interferon alpha therapy in atopic dermatitis of Besnier\u2019s prurigo pattern with normal serum IgE and blood eosinophil fraction: a randomized case-controlled study","volume":"13","author":"Noh","year":"2001","journal-title":"Cytokine"},{"key":"10.1016\/j.cgh.2006.06.010_bib168","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archderm.141.1.85","article-title":"Necrolytic acral erythema: a patient from the United States successfully treated with oral zinc","volume":"141","author":"Abdallah","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib169","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.jaad.2003.09.017","article-title":"Necrolytic acral erythema: response to combination therapy with interferon and ribavirin","volume":"50","author":"Hivnor","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib170","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/archderm.136.6.755","article-title":"Necrolytic acral erythema associated with hepatitis C: effective treatment with interferon alfa and zinc","volume":"136","author":"Khanna","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cgh.2006.06.010_bib171","first-page":"354","article-title":"Histological study of necrolytic acral erythema","volume":"100","author":"Abdallah","year":"2004","journal-title":"J Ark Med Soc"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356506005659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356506005659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T01:26:40Z","timestamp":1707182800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356506005659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":171,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S1542356506005659"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2006.06.010","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}